0001209191-20-054142.txt : 20201007 0001209191-20-054142.hdr.sgml : 20201007 20201007165014 ACCESSION NUMBER: 0001209191-20-054142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201001 FILED AS OF DATE: 20201007 DATE AS OF CHANGE: 20201007 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reilly Thomas Charles CENTRAL INDEX KEY: 0001827590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36279 FILM NUMBER: 201229506 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cara Therapeutics, Inc. CENTRAL INDEX KEY: 0001346830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-406-3700 MAIL ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 FORMER COMPANY: FORMER CONFORMED NAME: Cara Therapeutics Inc DATE OF NAME CHANGE: 20051213 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-01 0 0001346830 Cara Therapeutics, Inc. CARA 0001827590 Reilly Thomas Charles C/O CARA THERAPEUTICS, INC. 4 STAMFORD PLAZA, 107 ELM STREET STAMFORD CT 06902 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 12.74 2020-10-01 4 A 0 175000 0.00 A 2030-10-01 Common Stock 175000 175000 D 25% of the shares vest and become exercisable on October 1, 2021; the balance of the shares vest and become exercisable in a series of 36 successive equal monthly installments at the end of each calendar month thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such date. /s/ Alison Haggerty, Attorney-in-Fact 2020-10-07